News Bioretec Oy

Equities

BRETEC

FI4000480454

Market Closed - Nasdaq Helsinki Other stock markets 11:09:00 2024-05-14 am EDT			5-day change	1st Jan Change
2.69 ^EUR	+1.51%		-1.10%	+12.08%

Apr. 05	Bioretec Oy Announces Pekka Simula Not Available for Re-Election to Board of Directors	CI
Mar. 22	Finland's Bioretec Gets US Patent Allowance for Magnesium Alloy Composition	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Resolutions of Bioretec Ltd's Annual General Meeting and the constitutive meeting of the Board of Directors	Apr. 26	AQ
Notice of Annual General Meeting (AGM) of Bioretec Ltd	Apr. 08	AQ
Notice of Annual General Meeting (AGM) of Bioretec Ltd	Apr. 05	AQ
Bioretec Oy Announces Pekka Simula Not Available for Re-Election to Board of Directors	Apr. 05	CI
Finland's Bioretec Gets US Patent Allowance for Magnesium Alloy Composition	Mar. 22	MT
Inside information: Bioretec's RemeOs™ biodegradable magnesium alloy composition has been allowed a patent by the U.S. Patent office	Mar. 21	AQ
Bioretec Ltd. Receives a Patent by the U.S. Patent Office for its RemeOs Magnesium Alloy Composition	Mar. 21	CI
Bioretec Ltd's Annual Report and Financial Statements 2023 published	Mar. 15	AQ
Bioretec Secures US FDA Breakthrough Device Designation for Spinal Interbody Cage Implant	Mar. 14	MT
Inside information: Bioretec has been granted FDA Breakthrough Device Designation status for its RemeOs™ Spinal Interbody Cage	Mar. 14	AQ
Bioretec Has Been Granted FDA Breakthrough Device Designation Status for its RemeOs Spinal Interbody Cage	Mar. 14	CI
Bioretec Expects EU Regulatory Approval for Trauma Screw in Q2	Mar. 11	MT
Bioretec's European Market Authorization for RemeOs Trauma Screw Proceeded to Expert Panel Evaluation	Mar. 08	CI
Bioretec Ltd's financial statements bulletin 2023: Another successful year in the growth trajectory	Feb. 16	AQ
Bioretec and Stephen Industries donate medical devices to Ukraine	Feb. 08	AQ
New shares in Bioretec Ltd subscribed with option rights have been registered into the Trade Register	Jan. 18	AQ
Bioretec Ltd - Managers' transactions	Jan. 05	AQ
Bioretec Ltd's schedule for financial reporting in 2024 and updates in the disclosure policy	Dec. 11	AQ
Bioretec to Initiate Search for New CEO	Nov. 16	MT
Inside information: Bioretec's Board of Directors to initiate a new CEO recruitment process	Nov. 16	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Bioretec Oy

Equities

BRETEC

FI4000480454

Summary

Filters